Mary Ann E. Moore Sells 8,108 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) Stock

Pediatrix Medical Group, Inc. (NYSE:MD) EVP Mary Ann E. Moore sold 8,108 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $16.00, for a total value of $129,728.00. Following the sale, the executive vice president now owns 135,810 shares of the company’s stock, valued at $2,172,960. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Pediatrix Medical Group Stock Down 1.8 %

NYSE:MD opened at $15.22 on Thursday. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.83. The stock has a 50 day moving average of $12.38 and a 200-day moving average of $9.77. The firm has a market capitalization of $1.31 billion, a PE ratio of -4.97, a price-to-earnings-growth ratio of 2.22 and a beta of 1.55. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $16.41.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Friday, November 1st. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. During the same period in the previous year, the business posted $0.29 EPS. Pediatrix Medical Group’s revenue was up .9% on a year-over-year basis. Analysts predict that Pediatrix Medical Group, Inc. will post 1.25 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on MD. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday. Jefferies Financial Group increased their target price on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Mizuho lifted their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Truist Financial increased their price objective on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, UBS Group boosted their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research report on Tuesday, November 5th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Pediatrix Medical Group presently has a consensus rating of “Hold” and a consensus price target of $16.10.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. BNP Paribas Financial Markets increased its stake in shares of Pediatrix Medical Group by 79.2% during the first quarter. BNP Paribas Financial Markets now owns 41,728 shares of the company’s stock valued at $419,000 after acquiring an additional 18,438 shares during the period. Empowered Funds LLC raised its stake in shares of Pediatrix Medical Group by 8.2% in the 1st quarter. Empowered Funds LLC now owns 235,124 shares of the company’s stock worth $2,358,000 after buying an additional 17,784 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in shares of Pediatrix Medical Group by 4.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 72,767 shares of the company’s stock worth $730,000 after buying an additional 3,142 shares in the last quarter. Illinois Municipal Retirement Fund lifted its holdings in shares of Pediatrix Medical Group by 8.8% in the first quarter. Illinois Municipal Retirement Fund now owns 49,526 shares of the company’s stock valued at $497,000 after buying an additional 4,013 shares during the period. Finally, ProShare Advisors LLC boosted its stake in Pediatrix Medical Group by 7.4% during the first quarter. ProShare Advisors LLC now owns 16,937 shares of the company’s stock valued at $170,000 after buying an additional 1,167 shares in the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.